Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia
Clinical trial NCT06080555 · COMPLETED
Trial details
- NCT number
- NCT06080555
- Sponsor
- Sichuan Huiyu Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-09
- Primary completion
- 2024-01-22
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.